Drug repositioning in pharmaceutical industry



At the Institute of Pharmaceutical Sciences (TIPS)’s journal club meeting held online on April 19, 2021, the topic of “Drug repositioning in pharmaceutical industry” was presented by MA. Rezvanfar. In this meeting, drug repositioning, as the use of a drug in an indication other than the one for which it was initially marketed was introduced. It was concluded that the main aim of drug repositioning is to combat the rising costs which this approach can dramatically affect the number of new drugs entering the pharmaceuticals market.